Covid 19 Vaccination in India Highlights: Govt orders 45 lakh Covaxin doses, to send 8 lakh doses to Mauritius, Philippines and Myanmar

By: |
New Delhi | Updated: January 19, 2021 7:03:38 pm

Covid 19 Vaccination in India Day 4 Live Updates: Out of the 580 cases of adverse events, 7 individuals were hospitalised – 3 cases in Delhi, 2 cases in Karnataka, and 1 each in Uttarakhand and Chhattisgarh.

Covid 19 Vaccine in India Covishield Covaxin side effectsCovid 19 vaccination in India: On Monday, 25 states held 7,704 Covid vaccination sessions and Karnataka and Odisha were leading the chart in terms of the number of beneficiaries vaccinated on January 18, as per details provided by the Central government.(Reuters image)

Covid 19 Vaccination in India Day 4 Highlights: Coronavirus vaccination in India today enters its fourth day and so far over 3.81 lakh individuals have received Serum Institute of India’s Covidshield and Bharat Biotech’s Covaxin across the country. As many as 580 cases of adverse events following Immunization have been reported so far. Two persons have died following vaccination but one of the deaths is not related to Covid vaccination and in another case, post mortem report is awaiting, the Ministry of Health and Family Welfare said in a statement. Meanwhile, Maharashtra is scheduled to begin the Covid vaccination drive today.

On Monday, 25 states held 7,704 Covid vaccination sessions and Karnataka and Odisha were leading the chart in terms of the number of beneficiaries vaccinated on January 18, as per details provided by the Central government. Out of the 580 cases of adverse events, 7 individuals were hospitalised – 3 cases in Delhi, 2 cases in Karnataka, and 1 each in Uttarakhand and Chhattisgarh.

Meanwhile,  Serum Institute of India, who has inked pact to manufacture Oxford-AstraZeneca Covid-19 vaccine in India, on Tuesday shipped as many as 30 boxes of Oxford-developed Covid-19 vaccine Covishield from its facility in Pune (Maharashtra) to Hyderabad in Telangana.

The Indian government on Tuesday issued a fresh Letter of Comfort to Bharat Biotech for another 45 lakh doses of its Covid-19 vaccine Covaxin. Of the 45 lakh doses, over 8 lakh doses will be supplied to some of the friendly countries such as Mauritius, the Philippines, and Myanmar, free of cost as good will gesture. The Hyderabad-based firm has earlier received purchase order for 55 lakh doses of Covaxin from the government.

Read More

Live Blog

Covid 19 Vaccination in India

Highlights

    18:35 (IST)19 Jan 2021
    Of those vaccinated, 0.18 pc were adverse events, says govt

    Of the total people vaccinated against COVID-19 so far, the government on Tuesday said 0.18 per cent were adverse events following immunisation, while 0.002 per cent had to be hospitalised which is fairly low. (PTI)

    17:53 (IST)19 Jan 2021
    Govt doctors association in Karnataka wants choice to pick COVID-19 vaccine

    An association of government doctors in Karnataka has demanded that health care workers be allowed their choice of the COVID-19 vaccine, saying there have been some concerns among a section of the fraternity over the present arrangement for making available the doses. (PIT)

    17:04 (IST)19 Jan 2021
     Concerns about adverse effects of COVID vaccines insignificant: Health Ministry

    The concerns about adverse effects and serious problems, as of now, seem to be insignificant. Data show that we are in a comfortable situation and we would like to reassure you that the two COVID19 vaccines are safe: Health Ministry (ANI)

    16:01 (IST)19 Jan 2021
    Covid-19 vaccine: SII, Bharat Biotech issue factsheets for Covishield, Covaxin

    The Indian government has started rolling out Covid-19 vaccine under emergency use for the healthcare professionals and the frontline workers in the first phase with Bharat Biotech’s Covaxin and Serum Institute of India’s Covishield. Both Bharat Biotech and Serum Institute have recently issued guidelines and precautions under which the vaccines need to be taken and when to be avoided. They have been claiming that they have put out the fact sheets in public domain since the time the products were shipped out after the regulatory approval. However, not many seem to have noticed, and some experts even unable to recall seeing it. READ MORE

    15:58 (IST)19 Jan 2021
    Number of people vaccinated against Covid-19

    A total of 4,54,049 beneficiaries have so far been vaccinated against COVID-19 in the country which is more than double the number of coronavirus active cases, the Union Health Ministry said on Tuesday. In a span of 24 hours, 2,23,669 people were vaccinated for COVID-19 across 3,930 sessions taking the cumulative total of people vaccinated to 4,54,049 (across 7,860 sessions conducted so far) in the country, the ministry said. PTI

    15:05 (IST)19 Jan 2021
    Vaccine Diplomacy: India to send COVISHIELD vaccine to Bangladesh soon

    It’s confirmed! Bangladesh is getting ready to receive 2 million doses of COVISHIELD later this week. This is the vaccine which has been produced by the Serum Institute of India and is based on the Oxford-AstraZeneca vaccine. The government of Bangladesh is making all arrangements to receive the 2 million doses which India is gifting to the neighbouring country and it will reach Hazrat Shahjalal International Airport, Dhaka soon. READ MORE

    15:00 (IST)19 Jan 2021
    Mumbai doctor reports adverse reaction after vaccine shot

    In another case of adverse reaction from the Coronavirus vaccine, a Mumbai based doctor has been admitted in the hospital 24 hours after he was vaccinated. Dr Jairaj Acharya, who is a doctor at the city’s V N Desai Hospital, complained of fever, dehydration, dizziness and loose motions hours after he got the shot at the hospital. READ MORE

    12:59 (IST)19 Jan 2021
    Maharashtra: Vaccination drive resumes in Mumbai, Pune after 2 days

    After a gap of two days, the Covid-19 vaccination drive resumed in Mumbai and Pune on Tuesday morning, but unlike the first day, there was hardly any rush of beneficiaries for taking jabs in the metropolis. The vaccination drive resumed at 9 centres in Mumbai and 28 centres in the neighbouring Pune district, according to a report by news agency PTI.

    12:14 (IST)19 Jan 2021
    Covid-19 Vaccine update: Bharat Biotech gets order for 45 lakh Covaxin doses

    Hyderabad-based Bharat Biotech has received an order from the Centre for another 45 lakh doses of Covid-19 vaccine, Covaxin, according to a report by PTI. Of the 45 lakh doses, over eight lakh doses will be supplied to some of the friendly countries such as Mauritius, the Philippines, and Myanmar, free of cost as goodwill gesture, the report said, citing sources.

    11:42 (IST)19 Jan 2021
    Covid-19 vaccine: Cambodia seeks India assistance

    Cambodia Prime Minister Hun Sen is seeking assistance from India for the provision of Covid-19 vaccines, reported ANI. India has produced its own vaccine which is scheduled to be rolled out to more than 300 million people this year. READ MORE

    11:09 (IST)19 Jan 2021
    Covid-19 vaccine: Serum Institute sends more Covishield vaccines to Telangana

    Serum Institute of India on Tuesday shipped as many as 30 boxes of Oxford-developed Covid-19 vaccine Covishield from its facility in Pune (Maharashtra) to Hyderabad in Telangana.

    10:56 (IST)19 Jan 2021
    Covid-19 in Jharkhand: 100 new cases, 4 more deaths

    The total number of positive coronavirus cases in Jharkhand increased to 1,17,786 on Tuesday, as 100 more people tested positive for Covid-19, a health department official said on Tuesday.

    10:19 (IST)19 Jan 2021
    COVID-19: Telangana reports 256 new cases, 2 deaths

    Telangana on Tuesday registered 256 fresh Covid-19 cases, taking the total number of Coronavirus infections in the state to nearly 2.92 lakh while the toll surged to 1,581 with two more deaths linked to the deadly virus.

    09:58 (IST)19 Jan 2021
    Covid 19 vaccination in India: India reports over 10K Coronavirus cases

    India has reported 10,064 new COVID19 cases, 17,411 discharges, and 137 deaths in the last 24 hours, according to details shared by Union Health Ministry. Total Coronavirus cases stood at 1,05,81,837. Active Covid cases are 2,00,528, total discharges are 1,02,28,753, and the Death toll is 1,52,556.

    09:55 (IST)19 Jan 2021
    Covid 19 vaccination in India: Odisha receives more Covishield vaccines

    Odisha is all set to receive the second consignment of Serum Institute of India's Covishield vaccine on Tuesday.

    09:53 (IST)19 Jan 2021
    Covid 19 vaccination in India: Deaths after Vaccination

    "Out of the two deaths reported, death of the 52 year male from Moradabad, UP (who was vaccinated on 16th Jan 2021 and died on evening of 17th Jan 2021) is not related to vaccination as per the post mortem report. Death was caused due to cardiopulmonary disease. The second death was of a male person aged 43 years, resident of Bellary, Karnataka. He was vaccinated on 16 Jan, 2021 and died today. The cause of death is anterior wall infarction with Cardiopulmonary failure. The post mortem is scheduled today at Vijayanagar Institute of Medical Sciences, Bellary, Karnataka," the Ministry of Health and Family Welfare said in a statement.

    09:52 (IST)19 Jan 2021
    Covid 19 vaccination in India: Side effects of Coronavirus vaccines

    A total of 580 cases of AEFI have been reported so far across India. Out of these, seven have required hospitalization. Of the three cases reported from Delhi, two have been discharged whereas once case with reporting fainting is under observation at Max Hospital, Patparganj.  The reported case of AEFI in Uttarakhand is stable and under observation at AIIMS, Rishikesh.  In Chhattisgarh, one person is under observation at the Govt. Medical College, Rajnandgaon. Of the two cases of AEFI in Karnataka, one is under observation at District Hospital, Chitradurga and the second person is under observation at General Hospital, Challakere, Chitradurga.

    An Adverse Event Following Immunization (AEFI) is an unexpected medical occurrence that follows immunization. It may or may not be related to the vaccine or vaccination process.
    Next Stories
    1Natco’s marketing partner gets USFDA nod for cancer treatment drug
    2COVID-19: India records 18,599 new cases, 97 fresh fatalities
    3EU regulator urges caution on Sputnik COVID-19 vaccine